Sun Pharmaceutical Industries Share Price Today - Live Blog for October 01, 2025

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.15%, with its current market value per share resting at ₹1,638.30. This development highlights the stock's appeal to investors.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.10%. At this moment, it's actively trading at ₹1,636.05, presenting an enticing opportunity for those in the market.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.39%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,634.50, but investors are assessing whether this is a temporary dip or a long-term trend.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.04%, signalling a challenging period. Currently trading at ₹1,640.40, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.20% uptick, and they are currently valued at ₹1,641.30, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.08%, and as of now, it's trading at ₹1,637.20 per share. This upward trajectory is attracting keen interest from investors.

Following a noteworthy 0.22% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,635.70. When it comes to valuation, this stock has a PE ratio of 36.8900, with the industry PE ratio at 33.8509.

Sun Pharmaceutical Industries Ltd experienced a -0.13% dip in its share price and is currently trading at ₹1,632.80. The stock has a PE ratio of 36.8900, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.16% uptick, and they are currently valued at ₹1,634.70, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.05% surge in its share price and is presently trading at ₹1,632.10, captivating the attention of market participants.

Sun Pharmaceutical Industries Ltd displayed price stability, with no changes, and is trading at ₹1,631.10. This sustained performance invites investors to assess whether the stock aligns with their long-term investment goals.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.12%, and it is currently trading at ₹1,632.00. Additionally, the stock maintains a PE ratio of 36.8900, while the industry PE is 33.8509.

Demonstrating a commendable 0.12% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,632.00. In terms of valuation, the stock maintains a PE ratio of 36.8900, while the industry PE ratio stands at 33.8509.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.12%, reaching the current market price of ₹1,632.00. This development underscores the stock's growing popularity.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.12%, and it is currently trading at ₹1,632.00. Additionally, the stock maintains a PE ratio of 36.8900, while the industry PE is 33.8509.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.10% drop, and it's now trading at ₹1,628.75 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

With a -0.10% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,628.75. The stock is currently trading at a PE of 36.8900, while the industry PE is 33.8509, prompting investors to assess its value proposition.

With a -0.03% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,631.20. The stock is currently trading at a PE of 36.8900, while the industry PE is 33.8509, prompting investors to assess its value proposition.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.55% increase in its share price and is currently trading at ₹1,632.70. This remarkable performance has caught the eye of investors.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.21% uptick, and they are currently valued at ₹1,625.45, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

With a -0.03% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,623.00. Investors should examine the factors driving this decline. The stock's PE ratio is 36.8900, whereas the industry PE ratio stands at 33.8509.

Sun Pharmaceutical Industries Ltd witnessed a -0.17% drop in its share price and is currently trading at ₹1,623.50. With the stock's PE at 36.8900 and the industry PE at 33.8509, investors are weighing their options.

Sun Pharmaceutical Industries Ltd's stock price surged by 0.13%, reaching the current market value of ₹1,622.55 per share. This surge is a testament to the stock's recent performance.

Sun Pharmaceutical Industries Ltd share price has declined by -0.35%, and it's currently trading at ₹1,619.90. The stock maintains a PE of 36.8900, while the industry PE is 33.8509, prompting discussions about its valuation.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.55% drop, and it's now trading at ₹1,623.80 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.33% uptick, and they are currently valued at ₹1,634.10, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

With a -0.08% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,628.40. Investors should examine the factors driving this decline. The stock's PE ratio is 36.8900, whereas the industry PE ratio stands at 33.8509.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.23% decline, and it currently trades at ₹1,631.80 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 1.35%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,634.80 per share.